Streetbeat News

Products Services

DXCM

The FDA has cleared Stelo, a glucose biosensor by Dexcom, for over-the-counter use in the US. It's designed for individuals 18 and older with Type 2 diabetes not on insulin therapy. Stelo, a small wearable sensor, provides glucose insights directly to a smartphone and is set to be available in summer 2024.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 9:29 pm

BOX

MSFT

Box has expanded its partnership with Microsoft by integrating Azure OpenAI Service into its platform, making Box AI available to Enterprise Plus plan customers. This integration allows Box customers to access advanced AI models while ensuring enterprise-grade security, privacy, and compliance standards.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 9:08 pm

CRWD

CrowdStrike announces the acquisition of Flow Security, aiming to expand its cloud security leadership by integrating Data Security Posture Management (DSPM) into its Falcon XDR platform. This acquisition will enable CrowdStrike to offer comprehensive real-time data protection for data in all states, both at rest and in motion, across cloud, on-premise, and application environments. The deal, predominantly cash with some equity, is expected to close in CrowdStrike's fiscal first quarter, subject to customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 9:03 pm

DDIV

IDAT

STX

Evercore ISI analyst Amit Daryanani reiterated an Outperform rating on Seagate Technology Holdings Plc (NASDAQ:STX) with a price target of $110, citing broad-based demand and pricing strength. The analyst expects Seagate to exceed March-quarter expectations and guide June and beyond ahead of street expectations. The cyclical recovery in the cloud and demand improvement with Chinese vendors are highlighted as key drivers. Additionally, pricing discipline across the HDD market is expected to improve Seagate's gross margin. Cantor Fitzgerald analyst C J Muse gave Seagate a Neutral rating with a $95 price target. Seagate is also included in the First Trust Dorsey Wright Momentum & Dividend ETF (NASDAQ:DDIV) and IShares Future Cloud 5G And Tech ETF (NYSE:IDAT).

Portfolio Pulse from Anusuya Lahiri

March 05, 2024 | 9:00 pm

IMMP

Immutep Limited (NASDAQ:IMMP) reported positive safety and initial efficacy data from the first 90mg dosing of eftilagimod alpha (efti) in combination with paclitaxel in a Phase 2/3 trial for metastatic breast cancer, showing no serious adverse events and a 50% overall response rate. Shares of IMMP soared by 11.90% to $2.63.

Portfolio Pulse from Vandana Singh

March 05, 2024 | 8:57 pm

SOLUSD

Solana (CRYPTO: SOL) has seen a 21% increase in the past week, despite a 1.4% drop in the last 24 hours, trading around $127. It briefly surpassed BNB Chain's market cap, with trading volumes surging by 75.5% to $6.9 billion. Solana announced token extensions, enhancing use cases for enterprises. Its total value locked is $2.7 billion, with significant contributions from Marinade, Jito, and Marginfi. Technical charts and traders suggest a bullish outlook, potentially reaching $200 if Bitcoin's price remains stable. The anticipation of an Ethereum ETF could further boost Solana's rally.

Portfolio Pulse from Khyathi Dalal

March 05, 2024 | 8:52 pm

COIN

Coinbase has acknowledged that some users are encountering errors during transactions and has stated that its team is investigating the issue, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 8:47 pm

META

Meta Platforms Inc. (NASDAQ:META) is urging Oculus users to migrate their accounts to Meta before the March 29 deadline to avoid losing access to content. This move is part of Meta's rebranding efforts from Facebook and aims to streamline user experience by transitioning Oculus Quest to Meta Quest VR headsets. The account migration, introduced in June 2022, allows users to use an alternative login method without needing a Facebook account.

Portfolio Pulse from Franca Quarneti

March 05, 2024 | 8:31 pm

BAX

DVA

FMS

NVO

Dialysis provider stocks DaVita Inc (DVA), Fresenius Medical Care AG (FMS), and Baxter International Inc (BAX) traded higher after Novo Nordisk A/S (NVO) announced successful trial results for semaglutide, easing concerns over its impact on the kidney care market. Despite initial fears, the 24% reduction in kidney disease progression and related deaths was at the lower end of expectations, leading to a relief rally in the shares of these companies.

Portfolio Pulse from Vandana Singh

March 05, 2024 | 8:21 pm

AMZN

TGT

WMT

Target (NYSE:TGT) reported better-than-expected holiday quarter results, with revenue and net income surpassing estimates. Shares surged 12% as Target announced a paid membership program to compete with Amazon (NASDAQ:AMZN) and Walmart (NYSE:WMT). The program, launching next month, aims to offer same-day delivery and other benefits for $49 per year. Despite a challenging year with sluggish sales and increased theft, Target is optimistic about its sales recovery through new initiatives.

Portfolio Pulse from Upwallstreet

March 05, 2024 | 8:15 pm